Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference
Clinical researchers from Roswell Park Comprehensive Cancer Center are among the experts invited to share insights and clinical best practices at the National Comprehensive Cancer Network (NCCN) 2026 Annual Conference March 27-29 in Orlando, Florida.
Clinical Scorecard: Roswell Park Faculty to Present at National Comprehensive Cancer Network 2026 Annual Conference
At a Glance
Category Detail
Condition Cancer Key Mechanisms Immunotherapy, CAR-T therapy, clinical trial access Target Population Patients with various cancers including neuroendocrine tumors, breast cancer, pancreatic cancer, and colon cancer Care Setting Comprehensive cancer centers
Key Highlights
Presentation of SurVaxM immunotherapy findings for neuroendocrine tumors Expert panel discussion on breast cancer case reviews Focus on operational excellence in cancer care delivery Research on predictors of outcomes after CAR-T therapy Machine learning models predicting depression in cancer patients Guideline-Based Recommendations
Diagnosis
Utilize machine learning models for early detection of mental health issues in cancer patients Management
Implement embedded thoracic oncology nurse coordinators for improved goals of care documentation Monitoring & Follow-up
Assess endothelial activation and stress index scores post-CAR T therapy Risks
Evaluate enrollment disparities in clinical trials for breast cancer Patient & Prescribing Data
Patients with neuroendocrine tumors, breast cancer, pancreatic cancer, and colon cancer
Access to CAR-T and CD3-bispecific T-cell engager clinical trials is critical for patient outcomes
Clinical Best Practices
Redesign care delivery to enhance patient-centered systems Utilize comprehensive data platforms for multimodal clinical data analysis Conduct multicenter analyses to understand treatment outcomes across demographics References
